symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
QNRX,4.1,0,152560,4047590,0,3.66-39.36,0.1,"Quoin Pharmaceuticals, Ltd.",USD,0001671502,US74907L1026,74907L102,NASDAQ Capital Market,NASDAQ,Biotechnology,https://quoinpharma.com,"Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.",Dr. Michael  Myers Ph.D.,Healthcare,US,4,703 980 4182,42127 Pleasant Forest Court,Ashburn,VA,20148-7349,,0,https://financialmodelingprep.com/image-stock/QNRX.png,2016-08-01,False,False,True,False,False
